Literature DB >> 30031571

Re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results from the International mRCC Database Consortium.

Jeffrey Graham1, Omar Abdel-Rahman1, Toni K Choueiri2, Daniel Y C Heng3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30031571     DOI： 10.1016/j.eururo.2018.07.004

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  7 in total

Review 1.  Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.

Authors:  Vishal Navani; Moira C Graves; Nikola A Bowden; Andre Van Der Westhuizen
Journal:  Br J Clin Pharmacol       Date:  2020-06-05       Impact factor: 4.335

2.  Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes.

Authors:  Suming Du; Jinhui Xu; Jiajia Shen; Xiaojin Zhang; Huanzhang Hu; Xinghua Huang
Journal:  Gastroenterol Res Pract       Date:  2022-06-28       Impact factor: 1.919

3.  Efficacy of Atezolizumab for Advanced Non-Small Cell Lung Cancer Based on Clinical and Molecular Features: A Meta-Analysis.

Authors:  Wenjie Liu; Gengwei Huo; Peng Chen
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

4.  Inhibitors of PD-1 in Non-Small Cell Lung Cancer: A Meta-Analysis of Clinical and Molecular Features.

Authors:  Gengwei Huo; Wenjie Liu; Peng Chen
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

5.  Effect of sex on the efficacy of patients receiving immune checkpoint inhibitors in advanced non-small cell lung cancer.

Authors:  Chengdi Wang; Wenliang Qiao; Yuting Jiang; Min Zhu; Jun Shao; Pengwei Ren; Dan Liu; Weimin Li
Journal:  Cancer Med       Date:  2019-06-04       Impact factor: 4.452

6.  Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis.

Authors:  Christopher J D Wallis; Mohit Butaney; Raj Satkunasivam; Stephen J Freedland; Sandip P Patel; Omid Hamid; Sumanta K Pal; Zachary Klaassen
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

7.  Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma.

Authors:  Gennadi Tulchiner; Renate Pichler; Hanno Ulmer; Nina Staudacher; Andrea Katharina Lindner; Andrea Brunner; Bettina Zelger; Fabian Steinkohl; Friedrich Aigner; Wolfgang Horninger; Martin Thurnher
Journal:  Cancer Immunol Immunother       Date:  2021-02-28       Impact factor: 6.968
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.